PITTSBURGH, Aug. 2 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), a partnership to put the region's life sciences industry on a fast track for growth, today announced that Revivicor has leased laboratory space in the PLSG Incubator.
Revivicor commercializes therapies that can treat and cure serious human disease through regenerative medicine; specifically, the replacement of cells, tissues, and organs. Focus is placed on treatments for diabetes and whole organ transplantation, developed from the significant advances made in the fields of xenografts, stem cells, and tolerance technologies.
"We are thrilled to operate a laboratory in the PLSG incubator," said David Ayares, Ph.D., Revivicor Chief Executive Officer and Chief Scientific Officer. "It is very exciting to bring this work to a region that is already leading the way in regenerative medicine and tissue engineering. We want to build on Pittsburgh's reputation as a global leader in these areas, ultimately saving lives."
"We are energized by the addition of Revivicor to the PLSG Incubator," said Doros Platika, M.D. PLSG Chief Executive Officer. "PLSG is pleased to give Revivicor a space in Pittsburgh where it can continue its late stage programs, while helping to provide the regenerative medicine unit ability to focus on emerging technologies in early stage development."
Revivicor is a newly-established spinout company of PPL Therapeutics plc delivering the technology and promise of regenerative medicine. Revivicor addresses large markets and solutions for diseases that have large unmet clinical need. Revivicor was formed as a spinout of PPL Therapeutics plc ("PPL plc"), to address the emerging field of regenerative medicine, and includes 25 dedicated professionals from PPL's US division in Virginia as well as a Pennsylvania subsidiary that will conduct pivotal animal and clinical studies involving pancreatic islet cells and whole organs.
About the PLSG Incubator
The PLSG Incubator is co-located with the PLSG administrative and support functions, which together occupy 17,000 square feet of space on the fourth floor of Bridgeside Point, better known as the Cellomics Building on Technology Drive in Pittsburgh. Incubator facilities consist of 40 percent lab and 60 percent office space and houses 13 life sciences organizations, which also have convenient access to other services programs offered by the PLSG.
About the PLSG
The Pittsburgh Life Sciences Greenhouse is a public/private partnership, founded by the University of Pittsburgh, Carnegie Mellon University, UPMC Health System, the Commonwealth of Pennsylvania and our regional foundation community. Together with private industry and advanced research and healthcare capabilities of our institutional partners, PLSG invests in and supports the growth of regional life sciences companies. The PLSG is focused on developing a portfolio of companies in the following industry sectors: drug discovery tools and targets, medical devices and diagnostics, tissues engineering and regenerative medicine and therapeutic strategies for neurological and psychiatric disorders.
Pittsburgh Life Sciences Greenhouse
CONTACT: Tim O'Brien of O'Brien Communications, +1-412-854-8845; or LynnBanaszak of Pittsburgh Life Sciences Greenhouse, +1-412-770-1353; orDavid Ayares, Ph.D., Chief Executive Officer - Chief Scientific Officer ofRevivicor, +1-540-961-5559